We are live on ! Find out more
BSX icon

Boston Scientific

1,708 hedge funds and large institutions have $131B invested in Boston Scientific in 2025 Q3 according to their latest regulatory filings, with 179 funds opening new positions, 767 increasing their positions, 554 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 767 | Existing positions reduced: 554

36% more first-time investments, than exits

New positions opened: 179 | Existing positions closed: 132

14% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $989M

1% more funds holding

Funds holding: 1,6871,708 (+21)

0.86% less ownership

Funds ownership: 91.53%90.67% (-0.86%)

7% less funds holding in top 10

Funds holding in top 10: 4239 (-3)

10% less capital invested

Capital invested by funds: $145B → $131B (-$14.2B)

Holders
1,708
Holders Change
+21
Holders Change %
+1.24%
% of All Funds
22.41%
Holding in Top 10
39
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-7.14%
% of All Funds
0.51%
New
179
Increased
767
Reduced
554
Closed
132
Calls
$1.13B
Puts
$989M
Net Calls
+$140M
Net Calls Change
-$85.7M
Name Holding Trade Value Shares
Change
Change in
Stake
GC
376
Guggenheim Capital
Illinois
$14.8M +$2.51M +24,195 +19%
CIBC World Market
377
CIBC World Market
Ontario, Canada
$14.5M -$810K -7,818 -5%
Pathstone Holdings
378
Pathstone Holdings
New Jersey
$14.5M -$231K -2,233 -1%
WG
379
Winton Group
United Kingdom
$14.4M +$15.3M +147,742 New
Wealthfront Advisers
380
Wealthfront Advisers
California
$14.3M -$165K -1,589 -1%
Nordea Investment Management
381
Nordea Investment Management
Sweden
$14M +$1.48M +14,262 +11%
Verition Fund Management
382
Verition Fund Management
Connecticut
$13.9M +$466K +4,503 +3%
WC
383
Westwind Capital
New Mexico
$13.8M +$14.6M +141,343 New
MFG
384
Merit Financial Group
Georgia
$13.8M +$649K +6,267 +5%
Lido Advisors
385
Lido Advisors
California
$13.8M +$1.55M +15,012 +12%
FP
386
Financial Perspectives
Minnesota
$13.3M +$209K +2,017 +2%
VLKIM
387
Van Lanschot Kempen Investment Management
Netherlands
$13.3M +$3.57M +34,519 +34%
Pacer Advisors
388
Pacer Advisors
Pennsylvania
$13.2M -$1.86M -17,945 -12%
SWIG
389
Strategic Wealth Investment Group
Kentucky
$13M +$13.8M +132,940 New
MGP
390
M&G plc
United Kingdom
$12.9M +$11.2M +107,854 +449%
DIA
391
Dana Investment Advisors
Wisconsin
$12.7M -$15.6M -150,709 -54%
BCM
392
Brookstone Capital Management
Illinois
$12.6M +$1.44M +13,906 +12%
TWC
393
TD Waterhouse Canada
Ontario, Canada
$12.5M +$993K +9,585 +8%
SLI
394
Sumitomo Life Insurance
Japan
$12.5M +$2.35M +22,663 +22%
EPIM
395
Evelyn Partners Investment Management
$12.4M +$12.6M +121,913 +2,638%
SC
396
Sapient Capital
Indiana
$12.3M -$150K -1,449 -1%
HFS
397
Hantz Financial Services
Michigan
$12.2M +$8.8M +84,953 +212%
ABTD
398
Arvest Bank Trust Division
Oklahoma
$12.2M -$72.7K -702 -0.6%
VIM
399
Vinva Investment Management
Australia
$12.1M +$5.87M +56,645 +83%
GI
400
GAMCO Investors
Connecticut
$12.1M -$125K -1,207 -1%

BSX Hedge Fund Activity: Q3 2025 in Review

1,708 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2025, worth a combined $131B — down 9.8% from $145B a quarter earlier.

Buyers outnumbered sellers: 179 funds opened new BSX positions and 132 closed out — a net gain of 47 holders — while 767 added to existing stakes and 554 trimmed.

The largest buyer was Parnassus Investments, adding an estimated $711M. The largest seller was Wellington Management Group, cutting an estimated $1.86B.

  • 1,708 institutional investors held Boston Scientific (BSX) as of Q3 2025, up from 1,687 in Q2 2025.
  • Funds reported $131B of Boston Scientific stock for Q3 2025, down 9.8% quarter-over-quarter.
  • 179 funds opened new Boston Scientific positions in Q3 2025 and 132 closed out, a net change of +47 holders.
  • The largest Boston Scientific buyer in Q3 2025 was Parnassus Investments, an estimated $711M added.
  • The largest Boston Scientific seller in Q3 2025 was Wellington Management Group, an estimated $1.86B sold.

Based on aggregated 13F filings for Q3 2025.